These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3019968)

  • 21. Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography.
    Souid AK; Newton GL; Dubowy RL; Fahey RC; Bernstein ML
    Cancer Chemother Pharmacol; 1998; 42(5):400-6. PubMed ID: 9771955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equilibrium dialysis studies of the binding of radioprotector compounds to DNA.
    Smoluk GD; Fahey RC; Ward JF
    Radiat Res; 1986 Aug; 107(2):194-204. PubMed ID: 3018831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic pathways of WR-2721 (ethyol, amifostine) in the BALB/c mouse.
    Shaw LM; Bonner HS; Brown DQ
    Drug Metab Dispos; 1994; 22(6):895-902. PubMed ID: 7895607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition of WR-1065 in the liver of tumor-bearing rats following regional vs systemic administration of amifostine.
    Levi M; DeRemer SJ; Dou C; Ensminger WD; Smith DE
    Biopharm Drug Dispos; 2004 Jan; 25(1):27-35. PubMed ID: 14716750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of both protein-bound and total S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood by high-performance liquid chromatography.
    Bonner HS; Shaw LM
    J Chromatogr B Biomed Sci Appl; 2000 Mar; 739(2):357-62. PubMed ID: 10755379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WR-2721, its derivatives and their radioprotective effects on mammalian cells in culture.
    Mori T; Watanabe M; Horikawa M; Nikaido P; Kimura H; Aoyama T; Sugahara T
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Jul; 44(1):41-53. PubMed ID: 6305861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplacental uptake of WR 2721 by the rat embryo.
    Davis ME; Conger AD; Sodicoff M
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):575-8. PubMed ID: 3030982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of WR-2721, WR-1065, and WR-33278 in plasma.
    Fahey RC; Newton GL
    Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1193-7. PubMed ID: 2987166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation.
    Molkentine JM; Fujimoto TN; Horvath TD; Grossberg AJ; Garcia CJG; Deorukhkar A; de la Cruz Bonilla M; Lin D; Samuel ELG; Chan WK; Lorenzi PL; Piwnica-Worms H; Dantzer R; Tour JM; Mason KA; Taniguchi CM
    Sci Rep; 2019 Feb; 9(1):1949. PubMed ID: 30760738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
    Rasey JS; Nelson NJ; Mahler P; Anderson K; Krohn KA; Menard T
    Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood thiols following amifostine and mesna infusions, a pediatric oncology group study.
    Souid AK; Fahey RC; Aktas MK; Sayin OA; Karjoo S; Newton GL; Sadowitz PD; Dubowy RL; Bernstein ML
    Drug Metab Dispos; 2001 Nov; 29(11):1460-6. PubMed ID: 11602522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
    Yuhas JM
    Cancer Res; 1980 May; 40(5):1519-24. PubMed ID: 6245795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypotensive mechanisms of amifostine.
    Ryan SV; Carrithers SL; Parkinson SJ; Skurk C; Nuss C; Pooler PM; Owen CS; Lefer AM; Waldman SA
    J Clin Pharmacol; 1996 Apr; 36(4):365-73. PubMed ID: 8728352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-performance liquid chromatographic assay using electrochemical detection for the combined measurement of amifostine, WR 1065 and the disulfides in plasma.
    Korst AE; Vermorken JB; van der Vijgh WJ
    J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):167-74. PubMed ID: 9200531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility study of the pharmacology of local application of amifostine (WR-2721) to the buccal mucosa in guinea pigs.
    Li C; Wang S; Huang T; Chen N; Ou M
    Pharmacology; 2013; 91(5-6):281-6. PubMed ID: 23736649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo dephosphorylation of WR-2721 monitored by 31P NMR spectroscopy.
    Knizner SA; Jacobs AJ; Lyon RC; Swenberg CE
    J Pharmacol Exp Ther; 1986 Jan; 236(1):37-40. PubMed ID: 3001292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of amifostine and its metabolites in patients.
    Korst AE; Eeltink CM; Vermorken JB; van der Vijgh WJ
    Eur J Cancer; 1997 Aug; 33(9):1425-9. PubMed ID: 9337685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degradation of 2-(3-aminopropylamino)-ethanethiol (WR-1065) by Cu-dependent amine oxidases and influence on glutathione status of Chinese hamster ovary cells.
    Meier T; Issels RD
    Biochem Pharmacol; 1995 Aug; 50(4):489-96. PubMed ID: 7646554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioprotectants: pharmacology and clinical applications of amifostine.
    Dorr RT
    Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):10-3. PubMed ID: 9794995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of cultured mammalian cells with WR-2721 and its thiol, WR-1065: implications for mechanisms of radioprotection.
    Purdie JW; Inhaber ER; Schneider H; Labelle JL
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 May; 43(5):517-27. PubMed ID: 6303973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.